Erbitux & Off label use

7.5%

of users reported Off label use

63.9%

also reported Severe reaction

67.9%

are men

Severe reaction

63.9%

Hospitalization

17.6%

Death

14.5%

Life-threatening condition

3.1%

Disability

1.0%

Erbitux: general information

30 - 39 years

3.2%

40 - 49 years

7.7%

50 - 59 years

19.8%

60 - 69 years

36.3%

70 - 79 years

26.5%

80 - 89 years

6.5%